---
title: "NCA30963 GMP Mangafodipir"
ocid: "ocds-r6ebe6-0000662323"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000662323"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000662323.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000662323.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "UNIVERSITY OF EDINBURGH"
published: "2021-08-10"
---

# NCA30963 GMP Mangafodipir

Buyer: UNIVERSITY OF EDINBURGH  
Current stage: Award  
OCID: ocds-r6ebe6-0000662323

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000662323)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000662323.json)

## Summary

The University of Edinburgh, a prominent central purchasing body in the education sector, recently completed a tender process for the contract titled "NCA30963 GMP Mangafodipir." This procurement falls under the goods category and pertains to the formulation and Good Manufacturing Practice preparation of mangafodipir for clinical use. The contract award was signed on 29th July 2021 and involved a limited procurement method due to the unique technical requirements of the product. The delivery is to be made to the Centre for Cardiovascular Research at the University of Edinburgh located in Edinburgh, UK.

This tender presents significant opportunities for businesses experienced in complex pharmaceutical manufacturing and Good Manufacturing Practices, particularly those that can navigate the challenges of sterile fill products. Companies like Avomeen, who possess the necessary technical expertise and experience in handling such unique formulations, are well-positioned to participate in similar tenders. The procurement's emphasis on quality and technical capability makes it imperative for suppliers to demonstrate their proficiency in managing complex production processes, especially within the context of ongoing clinical trials and limited supply chains driven by high global demand.

## Notice

Formulation and Good Manufacturing Practice preparation of mangafodipir for clinical use in healthy volunteers and patients.

### Lot Information

Lot 1

Under Regulation Reg 33(1)(b)(ii) of the Public Contracts (Scotland) Regulations 2015, a contracting authority may use the negotiated procedure without the prior publication in the case of a public contract, based on the following justification: 2. Competition is absent for technical reasons (only if it is not caused by artificial narrowing down of the parameters of the procurement and no reasonable alternative or substitute exists);

Options: If the initially feasibility study is successful, the production and stability testing of mangafodipir is included in the procurement at the cost of 244,105 USD excluding VAT.

### Procurement Information

For the last 2 years, we have been trying to source further preparations of the mangafodipir. This has included a global search for suppliers which has been unsuccessful. We are working with a Norwegian company to provide the product but has proved unsuccessful although future supplies may be possible in 1-2 years' time. However, we have ongoing clinical trials and need a supply as soon as possible. We have now engaged with Avomeen (Element) who have previous experience with working with the product: this is quite unique with no other supplier having this experience. The product is rather complex to manufacture and formulate and given that they are the only current provider to generate the product and have the expertise, we have gone back to them. They seem to be the only company able to deal with the complexity of manufacture. The other issue is availability. The world's supply and capacity for sterile fill products is severely stretched due to the massive global demand for SARS-CoV2 vaccines. We have worked with Element to try alternative sterile fill premises but there is no capacity in other facilities for the immediate future.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG423907 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 10 Aug 2021 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 29 Jul 2021 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £84,995 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | UNIVERSITY OF EDINBURGH |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH1 1HT |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | City Centre |
| Westminster constituency | Edinburgh East and Musselburgh |
| Delivery location | TLM75 City of Edinburgh |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | AVOMEEN |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33696000 - Reagents and contrast media

## Release History

- 10 Aug 2021 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG423907

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG423907
  NCA30963 GMP Mangafodipir - Formulation and Good Manufacturing Practice preparation of mangafodipir for clinical use in healthy volunteers and patients.

## Notice URLs

- http://
- http://www.ed.ac.uk/schools-departments/procurement/supplying
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000662323

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000662323. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000662323.json.